IN2012DN00801A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00801A
IN2012DN00801A IN801DEN2012A IN2012DN00801A IN 2012DN00801 A IN2012DN00801 A IN 2012DN00801A IN 801DEN2012 A IN801DEN2012 A IN 801DEN2012A IN 2012DN00801 A IN2012DN00801 A IN 2012DN00801A
Authority
IN
India
Prior art keywords
adamts
expression
methods
useful
proteins
Prior art date
Application number
Inventor
Grillberger Leopold
Spenger Alexandra
Hasslacher Meinhard
Grillberger Rana
Reiter Manfred
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IN2012DN00801A publication Critical patent/IN2012DN00801A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/22—Zinc; Zn chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)

Abstract

The present invention provides culture mediums that are useful for the expression of ADAMTS proteins, such as ADAMTS13. Methods for the expression and purification of ADAMTS proteins are also provided. In some embodiments, the mediums and methods of the invention are useful for the expression of ADAMTS proteins having high specific activities. Also provided are ADAMTS, e.g., ADAMTS 13, protein compositions with high specific activities, which are expressed and purified according to the methods provided herein.
IN801DEN2012 2009-07-31 2010-07-30 IN2012DN00801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23047709P 2009-07-31 2009-07-31
PCT/US2010/044020 WO2011014838A1 (en) 2009-07-31 2010-07-30 Cell culture medium for adamts protein expression

Publications (1)

Publication Number Publication Date
IN2012DN00801A true IN2012DN00801A (en) 2015-06-26

Family

ID=42668009

Family Applications (1)

Application Number Title Priority Date Filing Date
IN801DEN2012 IN2012DN00801A (en) 2009-07-31 2010-07-30

Country Status (21)

Country Link
US (7) US8313926B2 (en)
EP (1) EP2459702B1 (en)
JP (5) JP5451884B2 (en)
KR (5) KR101574056B1 (en)
CN (2) CN104962539B (en)
AU (1) AU2010278751B2 (en)
BR (2) BR122021005965B1 (en)
CA (1) CA2769361A1 (en)
CO (1) CO6501191A2 (en)
EA (1) EA023193B1 (en)
ES (1) ES2583258T3 (en)
HR (1) HRP20160783T1 (en)
HU (1) HUE029110T2 (en)
IN (1) IN2012DN00801A (en)
MX (2) MX2012001261A (en)
NZ (1) NZ597727A (en)
PL (1) PL2459702T3 (en)
PT (1) PT2459702T (en)
SG (1) SG178194A1 (en)
SI (1) SI2459702T1 (en)
WO (1) WO2011014838A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2769361A1 (en) * 2009-07-31 2011-02-03 Baxter International Inc. Cell culture medium for adamts protein expression
SI2591094T1 (en) 2010-07-08 2018-12-31 Baxalta GmbH Method of producing recombinant adamts13 in cell culture
IL315908A (en) 2011-07-01 2024-11-01 Amgen Inc Mammalian cell culture
ES2633960T3 (en) 2012-10-15 2017-09-26 Bristol-Myers Squibb Company Processes of mammalian cell culture for protein production
WO2014159831A1 (en) 2013-03-13 2014-10-02 Merck Sharp & Dohme Corp. Adapted lepidopteran insect cells for the production of recombinant proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (en) 2013-03-15 2015-09-30 Regeneron Pharma SERUM FREE CELL CULTIVATION MEDIA
US10138467B2 (en) * 2013-10-14 2018-11-27 Ares Trading S.A. Medium for high performance mammalian fed-batch cultures
EP3926051B1 (en) 2014-06-04 2024-05-08 Amgen Inc. Methods for harvesting mammalian cell cultures
KR101867134B1 (en) * 2015-03-23 2018-06-12 한양대학교 산학협력단 Cell culture media for production of target material with high yield using mammalian cell, method for culturing cells and production of target material using the cell culture media
DK3298138T3 (en) * 2015-05-22 2022-10-31 Dupont Nutrition Biosci Aps ACETOLACTATE DECARBOXYLASE
TWI870789B (en) 2015-08-04 2025-01-21 美商再生元醫藥公司 Taurine supplemented cell culture medium and methods of use
CN116159130B (en) 2016-08-04 2025-09-09 武田药品工业株式会社 Treatment, amelioration and/or prevention of vasoocclusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome using ADAMTS13
AU2017391164B2 (en) * 2016-11-04 2024-01-04 Takeda Pharmaceutical Company Limited Adeno-associated virus purification methods
BR112020000127A2 (en) * 2017-07-06 2020-07-07 Regeneron Pharmaceuticals, Inc. method for selecting a soy hydrolyzate, and, glycoprotein
JP2021515584A (en) * 2018-03-16 2021-06-24 ジェンザイム・コーポレーション Methods for improving cell viability in production bioreactors
US20210189358A1 (en) * 2018-06-18 2021-06-24 Synthetic Biologics, Inc. Methods of making alkaline phosphatase agents
US20220339266A1 (en) 2019-10-04 2022-10-27 The Children's Medical Center Corporation Adamts13 treatment to enhance graft survival
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
AU2020398830C1 (en) 2019-12-06 2023-04-27 Regeneron Pharmaceuticals, Inc. Anti-VEGF protein compositions and methods for producing the same
JP2023521658A (en) 2020-04-02 2023-05-25 武田薬品工業株式会社 ADAMTS13 variants, compositions and uses thereof
MX2022013812A (en) 2020-05-08 2022-12-15 Regeneron Pharma Vegf traps and mini-traps and methods for treating ocular disorders and cancer.
JP2023526546A (en) 2020-05-22 2023-06-21 武田薬品工業株式会社 ADAMTS13 compositions and methods for treatment and diagnosis of complications of coronavirus disease
WO2021246557A1 (en) * 2020-06-05 2021-12-09 주식회사 프로앱텍 Urate oxidase-albumin conjugate having certain number of conjugated albumins, and method for producing same
CN111808822B (en) * 2020-07-02 2024-01-12 北京百普赛斯生物科技股份有限公司 Feed supplement liquid for cell culture and method for improving recombinant HEK293 cell protein expression quantity

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
CZ280901B6 (en) 1988-10-06 1996-05-15 Hideaki Yamada Rhodococcus rhodochrous bacteria cultivation method
JPH0753104B2 (en) * 1989-02-28 1995-06-07 秀明 山田 Bacterial culture method
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
ATE429246T1 (en) 1994-11-10 2009-05-15 Baxter Healthcare Sa METHOD FOR PRODUCING BIOLOGICAL PRODUCTS IN PROTEIN-FREE CULTURE
AU703484B2 (en) 1995-02-23 1999-03-25 Quest International Services B.V. Peptides for tissue and cell culture media
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP2218775B1 (en) 1996-08-30 2015-01-28 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
IT1285158B1 (en) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio SOLUBLE POLYPEPTIDES WITH THE SERINO-PROTEASIS ACTIVITY OF NS3 OF THE HEPATITIS C VIRUS, AND PROCEDURE FOR THEIR PREPARATION AND
DK0929507T3 (en) 1996-10-07 2003-03-24 Solutia Inc Process for hydroxylation of benzene
EP1983044B1 (en) 1996-10-10 2016-08-10 Life Technologies Corporation Animal cell culture media comprising plant-derived nutrients
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT407255B (en) 1997-06-20 2001-02-26 Immuno Ag RECOMBINANT CELL CLONE WITH INCREASED STABILITY IN SERUM- AND PROTEIN-FREE MEDIUM AND METHOD FOR OBTAINING THE STABLE CELL CLONE
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (en) 1999-06-02 2002-07-25 Baxter Ag MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE
US6926894B2 (en) 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
JP4723862B2 (en) 2002-12-23 2011-07-13 フジフィルム マニュファクチャリング ユーロプ ビー．ブイ． Method for coating a cell culture support
CN1969043A (en) * 2004-04-16 2007-05-23 惠氏公司 ADAMTS-8 proteases and uses thereof
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
JP2007174948A (en) * 2005-12-27 2007-07-12 Noritsu Koki Co Ltd Enzyme water production equipment
JP4880997B2 (en) * 2005-12-28 2012-02-22 アルフレッサファーマ株式会社 Method for stabilizing ADAMTS13
DK2522717T3 (en) 2006-01-04 2014-04-22 Baxter Int Oligopeptide-free cell culture media
BRPI0622214A2 (en) * 2006-12-22 2012-01-03 Springer Carrier Ltda Air conditioning unit and Method of mixing air in one air conditioning unit
US20090067805A1 (en) 2007-09-10 2009-03-12 Victor Company Of Japan, Limited Recording and reproducing device
KR101798813B1 (en) * 2007-12-27 2017-11-16 박스알타 인코퍼레이티드 Cell culture processes
CA2769361A1 (en) * 2009-07-31 2011-02-03 Baxter International Inc. Cell culture medium for adamts protein expression

Also Published As

Publication number Publication date
WO2011014838A1 (en) 2011-02-03
US8759026B2 (en) 2014-06-24
US10072254B2 (en) 2018-09-11
US20170051270A1 (en) 2017-02-23
JP6883071B2 (en) 2021-06-09
KR101574056B1 (en) 2015-12-02
JP2016144471A (en) 2016-08-12
JP2019201661A (en) 2019-11-28
EP2459702A1 (en) 2012-06-06
SG178194A1 (en) 2012-03-29
CN102549145A (en) 2012-07-04
CN102549145B (en) 2015-05-20
KR101756354B1 (en) 2017-07-26
CN104962539A (en) 2015-10-07
HRP20160783T1 (en) 2016-08-12
JP2018093881A (en) 2018-06-21
US20140329294A1 (en) 2014-11-06
KR101573972B1 (en) 2015-12-02
ES2583258T3 (en) 2016-09-20
KR20170140411A (en) 2017-12-20
JP5936232B2 (en) 2016-06-22
HK1171790A1 (en) 2013-04-05
PT2459702T (en) 2016-08-02
US20190071660A1 (en) 2019-03-07
EA023193B1 (en) 2016-05-31
JP7083059B2 (en) 2022-06-09
KR101912552B1 (en) 2018-10-26
KR20120046301A (en) 2012-05-09
MX2012001261A (en) 2012-05-22
KR101808496B1 (en) 2017-12-12
US11254921B2 (en) 2022-02-22
AU2010278751A1 (en) 2012-02-09
CN104962539B (en) 2019-09-17
JP6511007B2 (en) 2019-05-08
US9127265B2 (en) 2015-09-08
US20150329848A1 (en) 2015-11-19
HUE029110T2 (en) 2017-02-28
JP5451884B2 (en) 2014-03-26
CO6501191A2 (en) 2012-08-15
AU2010278751B2 (en) 2014-05-15
JP2021112210A (en) 2021-08-05
KR20150138425A (en) 2015-12-09
SI2459702T1 (en) 2016-11-30
US10724024B2 (en) 2020-07-28
JP6567707B2 (en) 2019-08-28
US20110086413A1 (en) 2011-04-14
KR20170081747A (en) 2017-07-12
MX344970B (en) 2017-01-12
EP2459702B1 (en) 2016-05-04
CA2769361A1 (en) 2011-02-03
NZ597727A (en) 2013-08-30
BR122021005965B1 (en) 2022-01-25
BR112012002151A2 (en) 2020-03-03
BR112012002151B1 (en) 2021-07-06
US8313926B2 (en) 2012-11-20
US20130071906A1 (en) 2013-03-21
PL2459702T3 (en) 2016-12-30
US20200308566A1 (en) 2020-10-01
KR20150044981A (en) 2015-04-27
US9441216B2 (en) 2016-09-13
JP2013500724A (en) 2013-01-10
JP2014061005A (en) 2014-04-10
EA201270224A1 (en) 2012-09-28

Similar Documents

Publication Publication Date Title
IN2012DN00801A (en)
MX2010000348A (en) Single pluripotent stem cell culture.
MX2013003681A (en) Engineered nucleic acids and methods of use thereof.
IN2012DN03825A (en)
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
EA201200091A1 (en) STRAINS TALAROMYCES AND ENZYME COMPOSITIONS
MX336737B (en) Compositions and methods comprising subtilisin variants.
EP3486319A3 (en) Compositions and methods comprising serine protease variants
WO2010141801A3 (en) Reprogramming t cells and hematophietic cells
MX361862B (en) Compositions and methods comprising a lipolytic enzyme variant.
MX2016001315A (en) Variant enzymes.
MX2009005655A (en) Compositions and uses for an alpha-amylase polypeptide of bacillus species 195.
PH12015502408B1 (en) Purification of iduronate-2-sulfatase
GB0917002D0 (en) Improved shigella blebs
MX2012005782A (en) Lyophilization methods, compositions, and kits.
WO2012024573A3 (en) Compositions comrpising perivascular stem cells and nell-1 protein
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2009137778A3 (en) Methods and compositions for genetically engineering clostridia species
PH12013500851A1 (en) Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
ATE486128T1 (en) COMPOSITIONS AND METHODS FOR INCREASE THE PRODUCTION OF RECOMBINANT GAMMA-CARBOXYLATED PROTEINS
WO2009058451A3 (en) Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
EP2597949A4 (en) Sub-micron compositions
GB2500552A (en) Stable lactase drops
MX2009008903A (en) Cleaning compositions comprising alpha-galactosidase.